Analyst firms · Morgan Stanley · STAA
Morgan Stanley STAA price target and rating history
STAAR Surgical Company (STAA) · Health Care
Morgan Stanley rates STAAR Surgical Company (STAA) Underweight with a $13 price target, as of its latest action on Jan 16, 2026. It has published 3 rating actions on STAA since December 2023, including 0 upgrades and 1 downgrade. Across 5 firms with a STAA price target in the last 12 months, the median target is $27. Morgan Stanley's $13 is 52% below that.
- Current rating
- Underweight
- Price target
- $13
- Median target, all firms
- $27
- Actions on STAA
- 3
Morgan Stanley price target on STAA
Every Morgan Stanley rating on STAA
- Jan 16, 2026
- Jul 15, 2024
- Dec 4, 2023
How other firms rate STAA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stifel | Buy | $31 | Sep 29, 2026 |
| UBS | Sell | $20 | Jul 28, 2026 |
| Wedbush | Outperform | $40 | May 14, 2026 |
| Canaccord Genuity | Buy | $27 | Apr 9, 2026 |
| Morgan Stanley | Underweight | $13 | Jan 16, 2026 |
Questions about Morgan Stanley and STAA
- What is Morgan Stanley's price target for STAA?
- Morgan Stanley's latest stated price target for STAAR Surgical Company (STAA) is $13, from its action on Jan 16, 2026.
- What is Morgan Stanley's rating on STAA?
- Morgan Stanley rates STAA Underweight, a bearish rating, as of Jan 16, 2026.
- When did Morgan Stanley last change its view on STAA?
- On Jan 16, 2026, Morgan Stanley resumes coverage at Underweight, price target $13.
- How does Morgan Stanley's STAA target compare with other analysts?
- Across 5 firms with a STAA price target in the last 12 months, the median target is $27. Morgan Stanley's $13 is 52% below that.
More STAA rating histories
All Morgan Stanley ratingsSTAA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.